SABS
SAB Biotherapeutics, Inc. - Common Stock (SABS)
$89
About SAB Biotherapeutics, Inc. - Common Stock (SABS)
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. It produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. The company was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.
Details
Daily high
$2.93
Daily low
$2.76
Price at open
--
52 Week High
$5.15
52 Week Low
$2.10
Market cap
262.0M
Dividend yield
-
Volume
112
Avg. volume
708,974
P/E ratio
-1.73
SAB Biotherapeutics, Inc. - Common Stock News
Details
Daily high
$2.93
Daily low
$2.76
Price at open
--
52 Week High
$5.15
52 Week Low
$2.10
Market cap
262.0M
Dividend yield
-
Volume
112
Avg. volume
708,974
P/E ratio
-1.73